glp 1 injection site reaction Dermal Hypersensitivity to Semaglutide: Two Case Reports Tirzepatide-Induced Injection Site Reaction |

Food & Drug Administration (2024) FDA alerts healthcare providers, compounders, and patients of dosing errors associated with compounded injectable semaglutide products, U.S

Food intake, body weight, body mass content, energy intake, and total energy expenditure outcome measures were analysed as continuous variables and as end point variables and were not transformed

Still, it raises concerns about side effects, especially facial volume loss (Ozempic Face), which is now becoming a common topic in aesthetic medicine

indeed, not all commercial assays produce consistent or accurate results, and many exhibit problematic sensitivity and specificity (88)

Yang et al., 2023)

In the first experiment, a total of 60 rats were divided equally into control, OA-1, OA-5, OA-10, OA-20 and OA-28 groups